A Phase 3, Randomized, Double-blind, Placebo-Controlled, Multicenter Study to Evaluate Azetukalner in Moderate-to-Severe Major Depressive Disorder
Status: Active_not_recruiting
Location: See all (50) locations...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Phase 3
SUMMARY
X-NOVA3 is a Phase 3, multicenter, randomized, double-blind, placebo-controlled study to evaluate the clinical efficacy, safety, and tolerability of azetukalner as a monotherapy in adult participants diagnosed with Major Depressive Disorder (MDD)
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 74
Healthy Volunteers: f
View:
• Adults ≥18 and ≤74 years of age and experienced their first major depressive episode (MDE) prior to 50 years of age
• Body Mass Index (BMI) ≤40 kg/m2
• Meets the Diagnostic and Statistical Manual of Mental Disorders Fifth Edition Text Revised (DSM-5-TR) criteria for current major depressive disorder and is currently in an MDE, confirmed using the Mini International Neuropsychiatric Interview (MINI)
• Participant's current MDE has a duration of ≥6 weeks and ≤24 months.
Locations
United States
Alabama
Harmonex Neuroscience Research
Dothan
University of Alabama at Birmingham, Huntsville Regional Medical Campus
Huntsville
Arkansas
Pillar Clinical Research
Bentonville
SanRo Clinical Research Group
Bryant
California
Clinical Innovations Inc
Bellflower
Center for Neurohealth
La Jolla
Artemis Institute for Clinical Research
San Diego
California Neuroscience Research
Sherman Oaks
Pacific Clinical Research Management Group
Upland
Connecticut
Institute of Living
Hartford
Florida
Gulfcoast Clinical Research Center
Fort Myers
Sarkis Clinical Trials
Gainesville
Equipath Health and Research Tampa Bay, Llc
Riverview
Georgia
Delricht Research
Atlanta
Emory University Brain Health Center
Atlanta
Illinois
Advanced Quality Medical Research
Orland Park
Louisiana
Smart Trials, LLC
Jefferson
Massachusetts
Adams Clinical Boston
Boston
Activmed Practices & Research, Llc - Methuen
Methuen
Adams Clinical Watertown
Watertown
Vitalix Clinical, Inc
Worcester
Maryland
Pharmasite Research Inc.
Baltimore
Missouri
Psychiatric Care and Research Center
O'fallon
St. Charles Psychiatric Associates - Midwest Research Group